Buscar
01/01/2023
[Translated article] BAP1-inactivated Melanocytic Tumor: Dermoscopic Features to Aid Diagnosis [Tumor melanocítico inactivado a BAP1: claves para su diagnóstico dermatoscópico]
Fustà-Novell X., García-Herrera A., Yélamos O.. [Translated article] BAP1-inactivated Melanocytic Tumor: Dermoscopic Features to Aid Diagnosis [Tumor melanocítico inactivado a BAP1: claves para su diagnóstico dermatoscópico]. Actas Dermo-Sifiliograficas. 2023; 114(2)DOI:10.1016/j.ad.2022.11.008. PMID:36464005. IF:(Q/D).
01/01/2023
The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease
Olveira A., Augustin S., Benlloch S., Ampuero J., Suárez-Pérez J.A., Armesto S., Vilarrasa E., Belinchón-Romero I., Herranz P., Crespo J., Guimerá F., Gómez-Labrador L., Martín V., Carrascosa J.M.. The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease. Life-Basel. 2023; 13(2)DOI:10.3390/life13020419. PMID:36836776. IF:3.200(Q1/3D).
01/01/2023
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials
Simpson E.L., Pink A.E., Blauvelt A., Gooderham M., Armstrong A.W., Worm M., Katoh N., Peris K., Puig L., Barbarot S., Mark T., Steffensen L.A., Tindberg A.-M., Wollenberg A.. Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2023; 24(6)DOI:10.1007/s40257-023-00806-3. PMID:37682422. IF:8.600(Q1/1D).
01/01/2023
Race, Ethnicity, and Ancestry: A Short Review and Proposal for Consistent Classifications in Dermatology
Puig L.. Race, Ethnicity, and Ancestry: A Short Review and Proposal for Consistent Classifications in Dermatology. Actas Dermo-Sifiliograficas. 2023; 114(10)DOI:10.1016/j.ad.2023.07.013. PMID:37482290. IF:(Q/D).
01/01/2023
The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study
Rivera-Díaz R., Pozo T., Alfageme F., Díaz Ley B., Osorio G.F., Chico R., Vilarrasa E., Silvente C., Ciudad Blanco C., Romaní J., Martorell A., Fernández P., Romero Ferreiro C., Molina Leyva A.. The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study. Actas Dermo-Sifiliograficas. 2023; 114(9)DOI:10.1016/j.ad.2023.06.013. PMID:37331620. IF:(Q/D).
01/01/2023
Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results
Pereyra-Rodriguez J.J., Herranz P., Figueras-Nart I., Perez B., Elosua M., Munera-Campos M., Melgosa-Ramos J., Zaragoza V., Silvestre J.F., Campos-Domínguez M., Guilabert A., Miquel J., Alcantara-Luna S., de la Cueva P., Serra-Baldrich E., Armario-Hita J.C.. Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(3)DOI:10.18176/jiaci.0831. PMID:35671128. IF:6.700(Q1/2D).